Tamaki T - Search Results

1

Microparticles as Biomarkers of Blood Coagulation in Cancer.

Nomura S, Niki M, Nisizawa T, Tamaki T, Shimizu M. Nomura S, et al. Among authors: tamaki t. Biomark Cancer. 2015 Oct 1;7:51-6. doi: 10.4137/BIC.S30347. eCollection 2015. Biomark Cancer. 2015. PMID: 26462252 Free PMC article. Review.

2

TGFβ(1) and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP.

Fujita S, Nakanishi T, Yoshimura H, Hotta M, Nakamichi N, Tamaki T, Ishii K, Ito T, Nomura S. Fujita S, et al. Among authors: tamaki t. Thromb Res. 2012 Sep;130(3):415-9. doi: 10.1016/j.thromres.2012.06.002. Epub 2012 Jul 11. Thromb Res. 2012. PMID: 22789125 Clinical Trial.

3

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients.

Nomura S, Taniura T, Shouzu A, Omoto S, Inami N, Fujita S, Tamaki T, Yokoi T, Shimizu T, Ito T. Nomura S, et al. Among authors: tamaki t. Int J Gen Med. 2012;5:535-40. doi: 10.2147/IJGM.S31346. Epub 2012 Jun 18. Int J Gen Med. 2012. PMID: 22807641 Free PMC article.

4

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer.

Shimizu T, Yokoi T, Tamaki T, Kibata K, Inagaki N, Nomura S. Shimizu T, et al. Among authors: tamaki t. Oncol Lett. 2013 Mar;5(3):761-767. doi: 10.3892/ol.2013.1134. Epub 2013 Jan 15. Oncol Lett. 2013. PMID: 23426938 Free PMC article.

5

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy.

Kibata K, Tamaki T, Inagaki N, Ogata M, Shimizu T, Nomura S. Kibata K, et al. Among authors: tamaki t. Oncol Lett. 2013 Apr;5(4):1123-1128. doi: 10.3892/ol.2013.1178. Epub 2013 Feb 5. Oncol Lett. 2013. PMID: 23599750 Free PMC article.

6

Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation.

Ozasa R, Hotta M, Yoshimura H, Nakanishi T, Tamaki T, Fujita S, Nakamichi N, Miyaji M, Ishii K, Ito T, Nomura S. Ozasa R, et al. Among authors: tamaki t. Int Med Case Rep J. 2012 Jul 6;5:39-43. doi: 10.2147/IMCRJ.S33293. Print 2012. Int Med Case Rep J. 2012. PMID: 23754921 Free PMC article.

7

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature.

Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S. Inagaki N, et al. Among authors: tamaki t. Oncol Lett. 2013 Sep;6(3):676-680. doi: 10.3892/ol.2013.1461. Epub 2013 Jul 15. Oncol Lett. 2013. PMID: 24137389 Free PMC article.

8

Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.

Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S. Inagaki N, et al. Among authors: tamaki t. Lung Cancer. 2014 Jan;83(1):97-101. doi: 10.1016/j.lungcan.2013.08.020. Epub 2013 Sep 2. Lung Cancer. 2014. PMID: 24189108 Free article.

9

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports.

Ito T, Ozaki Y, Son Y, Nishizawa T, Amuro H, Tanaka A, Tamaki T, Nomura S. Ito T, et al. Among authors: tamaki t. J Med Case Rep. 2014 Jul 11;8:250. doi: 10.1186/1752-1947-8-250. J Med Case Rep. 2014. PMID: 25015229 Free PMC article.

10

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.

Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A, Nomura S. Omoto S, et al. Among authors: tamaki t. Diabetes Metab Syndr Obes. 2015 Jul 27;8:339-45. doi: 10.2147/DMSO.S84545. eCollection 2015. Diabetes Metab Syndr Obes. 2015. PMID: 26251624 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,064 results

Search Page

Filters